<DOC>
	<DOCNO>NCT00883792</DOCNO>
	<brief_summary>Colorectal cancer ( CRC ) major burden western country . The disease develop precursor lesion long time-interval . Colonoscopy detect remove CRC precursor lesion may thus effective CRC prevention . Many national international health organisation demand evidence randomise trial reduce incidence mortality target disease advocate population-wide cancer screening . However , colonoscopy screen prevention colorectal cancer establish United States several European country , randomised trial exist quantify possible benefit colonoscopy screening . NordICC randomise trial investigate effect colonoscopy CRC incidence mortality . NordICC multicentre , randomise trial Nordic country , Netherlands Poland . A minimum 66 000 individual , age 55-64 year , drawn randomly population registry participate country . 22 000 invited once-only colonoscopy ( 2:1 randomisation ) . Expected work-load 50 % compliance 11,000 colonoscopy . At screen examination , detect lesion biopsied remove whenever possible . The remain 44 000 individual ( control group ) offer screen examination ( care usual ) .The primary study aim CRC incidence CRC mortality 15 year follow-up , interim analysis 10 year follow-up . In intention-to-treat approach , risk reduction CRC mortality 25 % colonoscopy screen group compare control group expect 10 year follow-up , estimate 50 % compliance screen group .</brief_summary>
	<brief_title>The Northern-European Initiative Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>This study populationbased randomise control trial , randomisation individual age 5564 year live screen area directly Population Registries either screen group control group . Eligible person home address randomise group ( household randomisation ) . Individuals previous colorectal surgery ( resection , enterostomy ) Individuals need longlasting attention nursing service ( somatic psychosocial , mental retardation ) . Ongoing cytotoxic treatment radiotherapy malignant disease Severe chronic ( longer trial duration ) cardiac ( NYHA IIIIV ) lung disease Lifelong anticoagulant therapy Warfarin A coronary event require hospitalization last 3 month A cerebrovascular event last 3 month Resident abroad Return unopened letter invitation and/or reminder ( address unknown ) Message neighbour/family/post office death screenee ( updated Population Registry )</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>